San Francisco on Tuesday became the first major US city to effectively ban the sale and manufacture of electronic cigarettes, as concerns grow over a sharp rise in vaping among youths.
Jun 26, 2019
0
3
Relapse of disease following conventional treatments remains one of the central problems in cancer management, yet few therapeutic agents targeting drug resistance and tolerance exist. New research conducted at the Cancer ...
Apr 8, 2019
0
91
Burosumab, a new injectable medicine to treat X-linked hypophosphatemia (XLH), an inherited form of rickets, demonstrates superior improvements in rickets and other outcomes compared with conventional therapy in an international, ...
Mar 24, 2019
0
1
Meningiomas, a type of brain tumour, are usually easy to treat. However, there are a few subtypes that follow a very aggressive course and have high recurrence rates, i.e. there is a high risk of them coming back after treatment. ...
Nov 19, 2018
0
3
The most common health care-associated bacterial infection in hospitals in the United States is Clostridium difficile. This pathogen secretes toxins that trigger diarrhea and colitis in 500,000 patients annually, killing ...
Jul 6, 2018
0
2
An international team has designed the first potentially therapeutic photoactive drug, MRS7145, to fight Parkinson's disease, according to the new article in Journal of Controlled Release.
Jun 8, 2018
0
82
A naturally occurring compound found in cannabis may help to curb the frequency of epileptic seizures, suggests a review of the available evidence, published online in the Journal of Neurology Neurosurgery & Psychiatry.
Mar 6, 2018
0
6
In a factory just outside San Francisco, there's an upright stainless steel vat the size of a small car, and it's got something swirling inside.
Jul 25, 2017
0
2
(HealthDay)—For patients with rheumatoid arthritis (RA), hydrotherapy in addition to conventional drugs is associated with improved antioxidant status, according to a study published online June 14 in the International ...
Jun 20, 2017
0
0
Research by bioscientists at the University of Kent and the University of Queensland is expected to pave the way for new approaches to kill bacteria that no longer respond to conventional antibiotics.
Oct 27, 2016
0
0
